-
1
المؤلفون: Redon, Josep, Pichler, Gernot, Missed Dose Study Group: Redon, J, Pascual, Jm, Olivan Martinez, J, Martell, N, Calvo Gomez, C, Lembo, G, Benedetto, Fa, De Curtis, G, Desideri, G, Dognini, Gp, Ferri, C, Fogari, R, Ganau, A, Gargiulo, A, Gaudio, G, Germanò, G, Malatino, L, Bucci, M, Mos, L, Novo, S, Pedrinelli, Roberto, Perticone, F, Portaluppi, F, Mulé, G, Sarzani, R, Schillaci, G, Spagnuolo, V, Strazzullo, P, Taddei, S, Trimarco, B, Veglio, F, Verdecchia, P, Volpe, M, Tsioufis, C, Zakopoulos, N, Zamboulis, C, Schmieder, Re, Bönner, G, Sehnert, W, Haller, H, Scholze, J, Burnier, M, Hayoz, D, Asmar, R, Blacher, J, Benetos, A, Gosse, P, Mounier Vehier, C, Thuillez, C.
المساهمون: Redon, J, Pichler, G, Mule, G, Redon, Josep, Pichler, Gernot, Strazzullo, Pasquale
المصدر: JOURNAL OF HYPERTENSION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instnameمصطلحات موضوعية: Male, Settore MED/09 - Medicina Interna, Antihypertensive agents, Physiology, Missed Dose, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, 030204 cardiovascular system & hematology, Pharmacology, Essential hypertension, law.invention, 0302 clinical medicine, Diabetes mellitus, Randomized controlled trial, law, Angiotensin II Type 1 Receptor Blocker, Drug Combination, Perindopril, Medicine, 030212 general & internal medicine, Antihypertensive agent, Tetrazole, Imidazoles, Settore MED/37 - Neuroradiologia, Middle Aged, Calcium Channel Blockers, Drug Combinations, Treatment Outcome, Hypertension, Female, Essential Hypertension, Olmesartan, Calcium Channel Blocker, Cardiology and Cardiovascular Medicine, Type 2, circulatory and respiratory physiology, medicine.drug, Human, Adult, medicine.medical_specialty, Amlodipine, Blood pressure, Internal Medicine, Diabetes mellitu, missed dose, hypertension, therapeutic efficacy, Combination therapy, Urology, NO, Medication Adherence, 03 medical and health sciences, Double-Blind Method, Humans, amlodipine, antihypertensive agents, blood pressure, diabetes mellitus, olmesartan, perindopril, Imidazole, Aged, business.industry, Angiotensin-Converting Enzyme Inhibitor, medicine.disease, Angiotensin II Type 1 Receptor Blockers, Antihypertensive Agents, Diabetes Mellitus, Type 2, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9d51c0f5d113a0a36025d8153fef258Test
http://hdl.handle.net/10447/211213Test -
2
المؤلفون: Azmil H, Abdul-Rahim, Ana-Cristina, Perez, Rachael L, Fulton, Pardeep S, Jhund, Roberto, Latini, Gianni, Tognoni, John, Wikstrand, John, Kjekshus, Gregory Y H, Lip, Aldo P, Maggioni, Luigi, Tavazzi, Kennedy R, Lees, John J V, McMurray, Donata, Lucci
المصدر: Abdul-Rahim, A H, Perez, A-C, Fulton, R L, Jhund, P S, Latini, R, Tognoni, G, Wikstrand, J, Kjekshus, J, Lip, G Y H, Maggioni, A P, Tavazzi, L, Lees, K R, McMurray, J J V & Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) Committees and Investigators* 2015, ' Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials ', Circulation Research, vol. 131, no. 17, pp. 1486-1494 . https://doi.org/10.1161/CIRCULATIONAHA.114.013760Test
مصطلحات موضوعية: Male, New York Heart Association Class, Tetrazoles, heart failure, Kaplan-Meier Estimate, Natriuretic Peptide, Brain, risk factors, Sinus rhythm, atrial fibrillation, Rosuvastatin Calcium, Stroke, Randomized Controlled Trials as Topic, Aged, 80 and over, Sulfonamides, sinus rhythm, Hazard ratio, Atrial fibrillation, Middle Aged, stroke, Cardiology, Female, Cardiology and Cardiovascular Medicine, medicine.drug, Adult, medicine.medical_specialty, macromolecular substances, Physiology (medical), Diabetes mellitus, Internal medicine, Fatty Acids, Omega-3, medicine, Humans, Rosuvastatin, cardiovascular diseases, Aged, Proportional Hazards Models, business.industry, Biphenyl Compounds, Cardiovascular Agents, Stroke Volume, medicine.disease, Peptide Fragments, Fluorobenzenes, Diabetes Mellitus, Type 1, Pyrimidines, Heart failure, ventricular ejection fraction, Benzimidazoles, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de78ac819d42b6388da0f0eef2637aefTest
https://acuresearchbank.acu.edu.au/item/87091/risk-of-stroke-in-chronic-heart-failure-patients-without-atrial-fibrillation-analysis-of-the-controlled-rosuvastatin-in-multinational-trial-heart-failure-corona-and-the-gruppo-italiano-per-lo-studioTest